Hot Features
Premium
Inscrivez-vous pour des graphiques en temps réel, des outils d'analyse et des prix.
| Nom Action | Symbole Action | Marché | Type |
|---|---|---|---|
| XBiotech Inc | XBIT | NASDAQ | Action ordinaire |
| Variation Action | Variation Action% | Cours Dernier | Dernier échange
|
|
|---|---|---|---|---|
| 0,01 | 0,12% | 8,17 | 15:53:16 |
| Ouverture | Plus Bas | Plus Haut | Prix de clôture | Clôture Veille |
|---|---|---|---|---|
| 8,26 | 8,17 | 8,26 | 8,16 |
Actualités Recentes
| Date | Heure | Source | Titre |
|---|---|---|---|
| 07/2/2024 | 18:36 | EDGAR2 | Form SC 13G/A - Statement of acquisition of beneficial.. |
| 07/2/2024 | 18:01 | EDGAR2 | Form SC 13G/A - Statement of acquisition of beneficial.. |
| 05/1/2024 | 16:48 | EDGAR2 | Form 4 - Statement of changes in beneficial ownership of.. |
| 04/1/2024 | 15:00 | EDGAR2 | Form 8-K - Current report |
| 04/1/2024 | 15:00 | GLOBE | XBiotech to Begin Constructing New R&D Facility on its.. |
| 14/11/2023 | 15:00 | GLOBE | Dr. Alan Kivitz to Chair XBiotech’s Natrunix Program in.. |
| 09/11/2023 | 20:41 | EDGAR2 | Form 10-Q - Quarterly report [Sections 13 or 15(d)] |
| 26/9/2023 | 15:00 | GLOBE | XBiotech Announces Enrollment Completion of Phase I Clinical.. |
| 30/8/2023 | 15:00 | GLOBE | XBiotech Announces Enrollment Completion of Phase II,.. |
| 11/8/2023 | 17:18 | EDGAR2 | Form 10-Q - Quarterly report [Sections 13 or 15(d)] |
| 08/8/2023 | 17:47 | GLOBE | XBiotech Announces First Patient Begins Novel Natrunix.. |
| 22/5/2023 | 15:00 | GLOBE | FDA Authorizes Phase II Study for Natrunix in Rheumatoid.. |
| 17/5/2023 | 15:00 | GLOBE | XBiotech Commences Tender Offer to Purchase up to.. |
